- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
Flutisal
Dry Powder Inhalation Capsule (DPI)
Generic Name
Salmeterol + Fluticasone Propionate
Manufacturer
Incepta Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 5.00 (5 x 6: ৳ 150.00) Strip Price: ৳ 30.00
🔹 Indications
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
🔹 Pharmacology
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Dosage & Administration
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Interaction
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Contraindications
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Side Effects
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Pregnancy & Lactation
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Precautions & Warnings
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Pediatric Usage
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Storage Conditions
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
💡 Frequently Asked Questions
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled s...
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled s...
Flutisal is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled s...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.